Literature DB >> 17323714

Treatment options for atopic dermatitis.

Lucinda M Buys1.   

Abstract

Atopic dermatitis is a common inflammatory skin condition that usually affects children. It is a chronic disease, with periods of remission and flare-ups, that adversely affects the quality of life of patients and their families. Aggressive therapy with emollients is an important intervention for patients with atopic dermatitis. Patients should avoid individual disease triggers and allergens. Topical corticosteroids are the mainstay of treatment for flare-ups and are the standard to which other treatments are compared. Topical calcineurin inhibitors should not be used in patients younger than two years or in those who are immunosuppressed, and should be secondline therapies in other patients. Rarely, systemic agents (e.g., cyclosporine, interferon gamma-1b, oral corticosteroids) may be considered in adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323714

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  20 in total

1.  Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis.

Authors:  James Q Del Rosso; Sanjay Bhambri
Journal:  J Clin Aesthet Dermatol       Date:  2009-09

2.  Topical steroids to treat granulomatous mastitis: a case report.

Authors:  Fatih Altintoprak
Journal:  Korean J Intern Med       Date:  2011-09-13       Impact factor: 2.884

3.  Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis.

Authors:  Fatih Altintoprak; Taner Kivilcim; Omer Yalkin; Yener Uzunoglu; Zeynep Kahyaoglu; Osman Nuri Dilek
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

4.  Smartphone-based multispectral imaging: system development and potential for mobile skin diagnosis.

Authors:  Sewoong Kim; Dongrae Cho; Jihun Kim; Manjae Kim; Sangyeon Youn; Jae Eun Jang; Minkyu Je; Dong Hun Lee; Boreom Lee; Daniel L Farkas; Jae Youn Hwang
Journal:  Biomed Opt Express       Date:  2016-11-28       Impact factor: 3.732

5.  Immunoglobulin e, interleukin-18 and interleukin-12 in patients with atopic dermatitis: correlation with disease activity.

Authors:  Khaled Zedan; Zafar Rasheed; Yaser Farouk; Abdullateef A Alzolibani; Ghada Bin Saif; Hisham A Ismail; Ahmad A Al Robaee
Journal:  J Clin Diagn Res       Date:  2015-04-01

Review 6.  National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021).

Authors:  Mohammad I Fatani; Afaf A Al Sheikh; Mohammed A Alajlan; Ruaa S Alharithy; Yousef Binamer; Rayan G Albarakati; Khalidah A Alenzi; Amr M Khardaly; Bedor A Alomari; Hajer Y Almudaiheem; Ahmed Al-Jedai; Maysa T Eshmawi
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-04

7.  Dupilumab (Dupixent): An Interleukin-4 Receptor Antagonist for Atopic Dermatitis.

Authors:  Daniella D'Ippolito; Michele Pisano
Journal:  P T       Date:  2018-09

8.  Atopic dermatitis.

Authors:  Wade Watson; Sandeep Kapur
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

9.  Calcineurin A-α suppression drives nuclear factor-κB-mediated NADPH oxidase-2 upregulation.

Authors:  Aswathy M Cheriyan; Adaku C Ume; Cynthia E Francis; Keyona N King; Valerie A Linck; Yun Bai; Hui Cai; Robert S Hoover; Heping P Ma; Jennifer L Gooch; Clintoria R Williams
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-22

10.  Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures.

Authors:  T Iannitti; V Rottigni; B Palmieri
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.